298 related articles for article (PubMed ID: 15616593)
1. Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax.
Drysdale M; Heninger S; Hutt J; Chen Y; Lyons CR; Koehler TM
EMBO J; 2005 Jan; 24(1):221-7. PubMed ID: 15616593
[TBL] [Abstract][Full Text] [Related]
2. The
Liang X; Zhu J; Zhao Z; Zheng F; Zhang H; Wei J; Ji Y; Ji Y
Front Cell Infect Microbiol; 2017; 7():203. PubMed ID: 28603695
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional analysis of the Bacillus anthracis capsule regulators.
Drysdale M; Bourgogne A; Koehler TM
J Bacteriol; 2005 Aug; 187(15):5108-14. PubMed ID: 16030203
[TBL] [Abstract][Full Text] [Related]
4. Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice.
Wilson MK; Vergis JM; Alem F; Palmer JR; Keane-Myers AM; Brahmbhatt TN; Ventura CL; O'Brien AD
Infect Immun; 2011 Aug; 79(8):3012-9. PubMed ID: 21576337
[TBL] [Abstract][Full Text] [Related]
5. Bacillus anthracis genetics and virulence gene regulation.
Koehler TM
Curr Top Microbiol Immunol; 2002; 271():143-64. PubMed ID: 12224521
[TBL] [Abstract][Full Text] [Related]
6. atxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB.
Drysdale M; Bourgogne A; Hilsenbeck SG; Koehler TM
J Bacteriol; 2004 Jan; 186(2):307-15. PubMed ID: 14702298
[TBL] [Abstract][Full Text] [Related]
7. Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis.
Brézillon C; Haustant M; Dupke S; Corre JP; Lander A; Franz T; Monot M; Couture-Tosi E; Jouvion G; Leendertz FH; Grunow R; Mock ME; Klee SR; Goossens PL
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003455. PubMed ID: 25830379
[TBL] [Abstract][Full Text] [Related]
8. Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax.
Heninger S; Drysdale M; Lovchik J; Hutt J; Lipscomb MF; Koehler TM; Lyons CR
Infect Immun; 2006 Nov; 74(11):6067-74. PubMed ID: 16923785
[TBL] [Abstract][Full Text] [Related]
9. Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model.
Chand HS; Drysdale M; Lovchik J; Koehler TM; Lipscomb MF; Lyons CR
Infect Immun; 2009 Jan; 77(1):429-35. PubMed ID: 18981254
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk to the genes for Bacillus anthracis capsule synthesis by atxA, the gene encoding the trans-activator of anthrax toxin synthesis.
Uchida I; Makino S; Sekizaki T; Terakado N
Mol Microbiol; 1997 Mar; 23(6):1229-40. PubMed ID: 9106214
[TBL] [Abstract][Full Text] [Related]
11. Role of acpA and acpB in Bacillus anthracis capsule accumulation and toxin independent pathogenicity in rabbits.
Sittner A; Bar-David E; Glinert I; Ben-Shmuel A; Schlomovitz J; Levy H; Weiss S
Microb Pathog; 2021 Jun; 155():104904. PubMed ID: 33930422
[TBL] [Abstract][Full Text] [Related]
12. Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice.
Glomski IJ; Corre JP; Mock M; Goossens PL
Infect Immun; 2007 Oct; 75(10):4754-61. PubMed ID: 17635863
[TBL] [Abstract][Full Text] [Related]
13. Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax.
Makino S; Watarai M; Cheun HI; Shirahata T; Uchida I
J Infect Dis; 2002 Jul; 186(2):227-33. PubMed ID: 12134259
[TBL] [Abstract][Full Text] [Related]
14. Global effects of virulence gene regulators in a Bacillus anthracis strain with both virulence plasmids.
Bourgogne A; Drysdale M; Hilsenbeck SG; Peterson SN; Koehler TM
Infect Immun; 2003 May; 71(5):2736-43. PubMed ID: 12704148
[TBL] [Abstract][Full Text] [Related]
15. Whole genome sequencing and identification of Bacillus endophyticus and B. anthracis isolated from anthrax outbreaks in South Africa.
Lekota KE; Bezuidt OKI; Mafofo J; Rees J; Muchadeyi FC; Madoroba E; van Heerden H
BMC Microbiol; 2018 Jul; 18(1):67. PubMed ID: 29986655
[TBL] [Abstract][Full Text] [Related]
16. [Anthrax: early steps of the intracellular stage of infection development].
Bakhteeva IV; Titareva GM; Kravchenko TB; Mironova RI; Noskov AN
Mol Gen Mikrobiol Virusol; 2005; (4):3-9. PubMed ID: 16334217
[TBL] [Abstract][Full Text] [Related]
17. Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax.
Lovchik JA; Drysdale M; Koehler TM; Hutt JA; Lyons CR
Infect Immun; 2012 Jul; 80(7):2414-25. PubMed ID: 22526673
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
Jang J; Cho M; Lee HR; Cha K; Chun JH; Hong KJ; Park J; Rhie GE
Biochim Biophys Acta; 2013 Mar; 1830(3):2804-12. PubMed ID: 23201204
[TBL] [Abstract][Full Text] [Related]
19. Treatment of experimental anthrax with recombinant capsule depolymerase.
Scorpio A; Tobery SA; Ribot WJ; Friedlander AM
Antimicrob Agents Chemother; 2008 Mar; 52(3):1014-20. PubMed ID: 18160516
[TBL] [Abstract][Full Text] [Related]
20. Galactosylation of the Secondary Cell Wall Polysaccharide of Bacillus anthracis and Its Contribution to Anthrax Pathogenesis.
Chateau A; Lunderberg JM; Oh SY; Abshire T; Friedlander A; Quinn CP; Missiakas DM; Schneewind O
J Bacteriol; 2018 Mar; 200(5):. PubMed ID: 29229702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
